Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Geroscience|November 27, 2024
Plasma triacylglycerol length and saturation level mark healthy aging groups in humansWeisha Li, Bauke V Schomakers, Michel van Weeghel, et al.
Physiological Reports|June 20, 2023
Invasive and noninvasive markers of human skeletal muscle mitochondrial functionRodrigo Mancilla, Diego Pava-Mejia, Nynke van Polanen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2021
Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in HumansEmmani B M Nascimento, Michiel P B Moonen, Carlijn M E Remie, et al.
Nature Aging|April 28, 2023
Healthy aging and muscle function are positively associated with NAD<sup>+</sup> abundance in humansGeorges E Janssens, Lotte Grevendonk, Ruben Zapata Perez, et al.
Diabetes|January 1, 2016
Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese HumansMark J W Hanssen, Anouk A J J van der Lans, Boudewijn Brans, et al.
Diabetologia|February 2, 2022
The influence of bright and dim light on substrate metabolism, energy expenditure and thermoregulation in insulin-resistant individuals depends on time of dayJan-Frieder Harmsen, Jakob Wefers, Daniel Doligkeit, et al.
Diabetologia|May 31, 2020
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesityAnastasia Kalinovich, Nodi Dehvari, Alice Åslund, et al.
Molecular Metabolism|July 14, 2020
Day-night rhythm of skeletal muscle metabolism is disturbed in older, metabolically compromised individualsJakob Wefers, Niels J Connell, Ciarán E Fealy, et al.
Frontiers in Public Health|April 6, 2026
Socioeconomic determinants of shift work employment in Canada and the Netherlands: a cross-sectional analysis of data from the Canadian Longitudinal Study on Aging and the Hoorn StudyDennis B Campbell, Tucker Reed, Romy Slebe, et al.
Diabetes Care|April 16, 2021
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover TrialYvo J M Op den Kamp, Marlies de Ligt, Bas Dautzenberg, et al.
Pageof 12